Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/07/1996 | US5514573 Gene encoding transglutaminase derived from fish |
05/07/1996 | US5514570 Squash mosaic virus genes and plants transformed therewith |
05/07/1996 | US5514566 Methods of producing recombinant fibroblast growth factors |
05/07/1996 | US5514551 Compositions for the detection of Chlamydia trachomatis |
05/07/1996 | US5514548 Method for in vivo selection of ligand-binding proteins |
05/07/1996 | US5514544 Dna sequences for genetic engineering |
05/07/1996 | US5514543 Screening for genetic disorders |
05/07/1996 | US5514539 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
05/07/1996 | US5514409 Methods for coating invasive devices with inhibitors of thrombin |
05/07/1996 | US5514375 Flavivirus recombinant poxvirus vaccine |
05/07/1996 | CA2058934C Processes for the recovery of microbially produced chymosin |
05/07/1996 | CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
05/03/1996 | CA2161946A1 Method for probing the function of a protein |
05/02/1996 | WO1996012964A1 Receptor for a bacillus thuringiensis toxin |
05/02/1996 | WO1996012821A1 Method for characterising variability in telomere dna by pcr |
05/02/1996 | WO1996012816A1 Process for producing proteins |
05/02/1996 | WO1996012815A1 Improvement of an expression vector for production of recombinant proteins |
05/02/1996 | WO1996012814A1 Promoter sequence from potato |
05/02/1996 | WO1996012813A1 Promoter from a plant alpha-amylase gene |
05/02/1996 | WO1996012812A1 A method of reducing the level of sugar in an organism |
05/02/1996 | WO1996012811A2 Yeast telomerase components and methods using them |
05/02/1996 | WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
05/02/1996 | WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
05/02/1996 | WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same |
05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
05/02/1996 | WO1996012806A1 Calcineurin interacting protein compositions and methods |
05/02/1996 | WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
05/02/1996 | WO1996012804A2 Recombinant dna |
05/02/1996 | WO1996012803A1 Method for the ex vivo treatment of tumour cells from patients with cml |
05/02/1996 | WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
05/02/1996 | WO1996012801A1 Oral immunization with transgenic plants |
05/02/1996 | WO1996012800A1 Modified factor vii |
05/02/1996 | WO1996012797A1 Production and use of human and plant methyltransferases |
05/02/1996 | WO1996012796A1 Conditional transformation of genetically engineered cells |
05/02/1996 | WO1996012792A1 INTERLEUKIN-1β DEFICIENT TRANSGENIC ANIMALS |
05/02/1996 | WO1996012791A1 Human abh |
05/02/1996 | WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
05/02/1996 | WO1996012733A1 Major outer membrane protein cd of moraxella |
05/02/1996 | WO1996012503A1 Remedy for diseases caused by il-6 production |
05/02/1996 | WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
05/02/1996 | WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
05/02/1996 | WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
05/02/1996 | WO1996012397A2 Recombinant antibody capable of binding to pna/nucleic acid complexes |
05/02/1996 | WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor |
05/02/1996 | WO1996003997A3 Treatment of cancer using hsv mutant |
05/02/1996 | WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
05/02/1996 | WO1995027732A3 Circularly permuted ligands and circularly permuted chimeric molecules |
05/02/1996 | WO1994025604A3 Steroid 21-hydroxylase fragments and assays using the same |
05/02/1996 | DE4439748A1 Verfahren zur Veränderung des Blühverhaltens bei Pflanzen Processes for modifying the flowering behavior of plants |
05/02/1996 | DE19538001A1 Bakteriophagenresistenz codierende Plasmide Bakteriophagenresistenz encoding plasmids |
05/02/1996 | CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
05/02/1996 | CA2416318A1 Soluble, recombinant botulinum toxin proteins |
05/02/1996 | CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
05/02/1996 | CA2203280A1 Modified factor vii |
05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
05/02/1996 | CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
05/02/1996 | CA2202991A1 Interleukin-1.beta. deficient transgenic animals |
05/02/1996 | CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
05/02/1996 | CA2202896A1 Promoter sequence from potato |
05/02/1996 | CA2202895A1 A method of reducing the level of sugar in an organism |
05/02/1996 | CA2202130A1 Recombinant dna |
05/02/1996 | CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
05/02/1996 | CA2200465A1 Improvement of an expression vector for production of recombinant proteins |
05/02/1996 | CA2200427A1 Receptor for a bacillus thuringiensis toxin |
05/01/1996 | EP0709468A1 A process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification, a diagnostic assay employing said process, a kit and a container suitable for carrying out said process or assay |
05/01/1996 | EP0709467A2 Compositions and methods for the detection of chlamydia trachomatis |
05/01/1996 | EP0709466A2 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences |
05/01/1996 | EP0709462A2 Rapid and efficient regeneration of transgenic plants |
05/01/1996 | EP0709461A1 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide |
05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
05/01/1996 | EP0709459A2 Modified biological material |
05/01/1996 | EP0709455A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
05/01/1996 | EP0709396A1 Gamma T cell receptor and methods for detection |
05/01/1996 | EP0709096A2 Pharmaceutical conditionning unit containing plasminogen activators for a multiple bolus delivery |
05/01/1996 | EP0708922A1 Identification of ligands by selective amplification of cells transfected with receptors |
05/01/1996 | EP0708877A1 Method for repairing a combustion chamber assembly |
05/01/1996 | EP0708841A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
05/01/1996 | EP0708840A1 Improved methods for detecting nucleic acid sequences |
05/01/1996 | EP0708839A1 Improved nucleic acid reactions |
05/01/1996 | EP0708838A1 Use of heparanase to identify and isolate anti-heparanase compound |
05/01/1996 | EP0708835A1 Fruit specific promoters |
05/01/1996 | EP0708834A1 FORMATION OF AND METHODS FOR THE PRODUCTION OF LARGE $i(BACILLUS THURINGIENSIS) CRYSTALS WITH INCREASED PESTICIDAL ACTIVITY |
05/01/1996 | EP0708833A1 Herpes simplex virus type-2 protease |
05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
05/01/1996 | EP0708831A1 Density enhanced protein tyrosine phosphatases |
05/01/1996 | EP0708830A1 $i(BACILLUS THURINGIENSIS) ISOLATES AND TOXINS |
05/01/1996 | EP0708829A1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
05/01/1996 | EP0708828A1 Obtaining nucleic acids |
05/01/1996 | EP0708827A1 Purification method and apparatus |
05/01/1996 | EP0708826A1 Production and application of transgenic mushroom mycelium and fruitbodies |
05/01/1996 | EP0708825A1 A fungal protein disulfide isomerase |
05/01/1996 | EP0708824A1 An enzyme with acetyl esterase activity |
05/01/1996 | EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
05/01/1996 | EP0708659A1 Hiv envelope polypeptides |
05/01/1996 | EP0708658A1 Recombinant cytomegalovirus vaccine |
05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
05/01/1996 | EP0708655A1 Methods of using insulin-like growth factor binding proteins |
05/01/1996 | EP0708653A1 Assay and reagents for identifying anti-proliferative agents |
05/01/1996 | EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |